Effects of hypertonic sodium chloride solution on the electrophysiologic alterations caused by bupivacaine in the dog heart

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 4, 2003, Pages 531-540

  Scalabrini, A ^a   Corregiari, F ^a   Rocha e Silva, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiac electrophysiology; Cardiotoxicity; Hypertonic solutions; Intraventricular conduction; Local anesthetics; Sodium ion

Indexed keywords

BUPIVACAINE; GLUCOSE; HYPERTONIC SOLUTION; LITHIUM CHLORIDE; MANNITOL; PENTOBARBITAL; SODIUM CHLORIDE; SODIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONDUCTION; MALE; NONHUMAN; QRS COMPLEX;

ANIMALIA; CANIS FAMILIARIS;

EID: 0038057909     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2003000400018     Document Type: Article

References (35)

1. Covino BG & Vassallo HG (1986). Local Anesthetics: Mechanisms of Actions and Clinical Use, Grunne & Stratton, Inc., New York, NY, USA, 29-55.
2. Vaugham-Williams EM (1984). A classification of antiarrhythmic actions reassessed after a decade of new drugs. Journal of Clinical Pharmacology, 24: 129-147.
3. Campbell TJ (1983). Kinetics of onset of rate-dependent effects of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovascular Research, 17: 334-352.
4. Clarkson CW & Hodeghem LM (1995). Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology, 62: 396-405.
5. Anderson KP, Walker R, Lux RL, Ershler PR, Menlove R, Williams MR, Krall R & Moddrelle D (1990). Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Circulation, 81: 1024-1038.
6. Kasten GW (1986). Amide local anesthetic alterations of effective refractory period temporal dispersion: relationship to ventricular arrhythmias. Anesthesiology, 65: 61-66.
7. Castle NA (1990). Bupivacaine inhibits the transient outward K current but not the inward rectifier in rat ventricular myocytes. Journal of Pharmacology and Experimental Therapeutics, 255: 1038-1064.
8. Courtney KR & Kendig JJ (1988). Bupivacaine is an effective potassium channel blocker in heart. Biochimica et Biophysica Acta, 939: 163-166.
9. Boettner RB, Dunbar RW, Haley JV & Morrow DH (1972). A comparison of the antiarrhythmic effects of bupivacaine and lidocaine. Southern Medical Journal, 65: 1328-1330.
10. Chapin JC, Kushins LG, Munson ES & Schick LM (1980). Lidocaine, bupivacaine, etidocaine and epinephrine-induced arrhythmias during halothane anesthesia in dogs. Anesthesiology, 52: 23-25.
11. Dunbar RW, Boettner RB, Glatz RN, Pennington RE & Morrow DH (1970). The effect of mepivacaine, bupivacaine and lidocaine on digitalis-induced ventricular arrhythmias. Anesthesia and Analgesia, 49: 761-766.
12. Romanoff ME & Ellis Jr JS (1991). Bupivacaine toxicity after stellate ganglion block. Anesthesia and Analgesia, 72: 546-548.
13. Gibson P & Murrell D (1991). Complications of epidural analgesia. Anaesthesia and Intensive Care, 19: 282-284.
14. Salemi S & Gristina E (1991). Toxic effects of bupivacaine on heart conduction during peridural anesthesia. Minerva Anestesiologica, 57: 468-469.
15. Wolff AP, Hasenbos MA, Liem TH & Gielen MJ (1992). Accidental overdose of epidural bupivacaine and sufentanil. Regional Anesthesia, 17: 237-238.
16. Kinney WW, Kambam JR & Wright W (1991). Propranolol pretreatment reduces cardiorespiratory toxicity due to plain, but not epinephrine-containing, intravenous bupivacaine in rats. Canadian Journal of Anaesthesia, 38: 533-536.
17. Bernards CM & Artu AA (1991). Hexamethonium and midazolam terminate dysrhythmias and hypertension caused by intracerebroventricular bupivacaine in rabbits. Anesthesiology, 74: 89-96.
18. Hyman SA, Kinney WW, Horn JL, Skelley CC & Kambam JR (1992). Nimodipine reduces the toxicity of intravenous bupivacaine in rats. Anesthesia and Analgesia, 74: 851-855.
19. De Kock M, Le Polain B, Henin D, Vandewalle F & Scholtes JL (1993). Clonidine pretreatment reduces the systemic toxicity of intravenous bupivacaine in rats. Anesthesiology, 79: 282-289.
20. Fujita S, Enoch S, Yasukawa T & Sari A (1998). Lidocaine increases the ventricular fibrillation threshold during bupivacaine induced cardiotoxicity in pigs. British Journal of Anaesthesia, 80: 218-222.
21. Rocha e Silva M, Velasco IT, Nogueira da Silva RI, Oliveira MA, Negraes GA & Oliveira MA (1987). Hyperosmotic sodium salts reverse severe hemorrhagic shock other solutes do not. American Journal of Physiology, 253: H751-H762.
22. Velasco IT, Pontieri V, Rocha e Silva M & Lopes OU (1980). Hyperosmotic NaCl and severe hemorrhagic shock. American Journal of Physiology, 239: H664-H673.
23. Wang BW, Chiou YH, Chen WB, Peng TY & Leung HK (1997). Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica, 35: 85-90.
24. Simonetti MPB, Cremonesi E & Rodrigues IJ (1987). Influência do NaCl a 7,5% (2400 mOsm) nos efenos cardiocirculatórios da bupivacaina em cães anestesiados. Revista Brasileira de Anestesiologia, 37 (Suppl 7): 88 (Abstract).
25. Lynch C (1986). Depression of myocardial contractility in vitro by bupivacaine. Anesthesia and Analgesia, 65: 551-559.
26. Ehara T & Hasegawa JI (1983). Effects of hypertonic solution on action potential and input resistance in the guinea-pig ventricular muscle. Japanese Journal of Physiology, 33: 151-167.
27. Turgeon J, Wisialowski T, Wong W, Altemeier W, Wikswo J & Roden D (1992). Suppression of longitudinal versus transverse conduction by sodium channel block. Circulation, 85: 221-226.
28. Bajaj A, Woosley R & Roden D (1989). Acute electrophysiologic effects of sodium administration in dogs treated with α-desmethyl encainide. Circulation, 80: 994-1002.
29. Pentel PR, Fifield J & Salermo DM (1990). Lack of effect of hypertonic sodium bicarbonate on QRS duration in patients taking therapeutic doses of class IC antiarrhythmic drugs. Journal of Clinical Pharmacology, 30: 789-794.
30. Barber M, Wendt D, Starmer C & Grant A (1992). Blockade of cardiac sodium channels: competition between the permeant ion and antiarrhythmic drugs. Journal of Clinical Investigation, 90: 368-381.
31. Ujhelyi MR, Schur M, Frede T, Bottorff MB, Gabel M & Markel ML (1997). Hypertonic saline does not reverse the sodium channel blocking actions of lidocaine: evidence from electrophysiologic and defibrillation studies. Journal of Cardiovascular Pharmacology, 29: 61-68.
32. Huang YF, Pryor ME, Mather LE & Veering BT (1998). Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesthesia and Analgesia, 86: 797-804.
33. Gristwood R, Bardsley H, Baker H, Watson N & Nimmo W (1994). Reduced cardiotoxicity of levobupivacaine compared with racemic bupivacaine (Marcaine): new clinical evidence. Expert Opinion on Investigational Drugs, 3: 1209-1212.
34. Valenzuela C, Synders DJ, Bennett PB, Tamango J & Hondeghem LM (1995). Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation, 92: 3014-3024.
35. Vanhoutte F, Vereecke J, Verbeke N & Carmeliet E (1991). Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea pig papillary muscle. British Journal of Pharmacology, 103: 1275-1281.